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Research Article
Gel-free IEF in a membrane-sealed
multicompartment cell for proteome
prefractionation
A minidevice for performing gel-free proteome prefractionation via conventional IEF in
soluble carrier ampholyte buffers is reported here. It consists of a compact block of poly-
oxymethylene in which eight samples and two electrode chambers are machined. Each of
the eight sample chambers can be filled with up to 120 mL of sample and has the following
size: 7 mm width, 3 mm depth and 10 mm height. The anodic and cathodic compartments
have the same width and height as the sample chambers, but with a depth of 6 mm, thus
accepting up to 250 mL of electrodic solutions. Focusing is in general accomplished in 2 h
with a voltage gradient of up to 1000 V (7 cm electrode distance). Easy fractionation and
collection of the content of the eight chambers is achieved by simply pressing a rubber
diaphragm against the edges of the thin walls separating each well, this automatically
breaking liquid continuity. The performance of this device has been tested by sub-
fractionating total cell lysates of a human cancer cell line (U2Os) and of Escherichia coli
bacterial cells, and by analysing the content of each chamber by mono-dimensional SDS-
PAGE and 2-D maps.
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1 Introduction
In this third millennium, characterized by an exasperating
march towards miniaturization at all costs (just to have a
glimpse at the field, one could consult a number of Special
Issues of Electrophoresis devoted to this topic, e.g. Electropho-
resis 2000, 21, pp. 1–254; ibid. 2001, 22, pp. 185–370 and pp.
3843–4031; ibid. 2002, 23, pp. 3459–3645, ibid. 2003, 24,
3521–3833), scientists have forgotten (or perhaps they never
knew) that IEF (still one of the leading techniques on today’s
separation science horizon) was born as a preparative tech-
nique in large-size columns (accommodating either 110 or
440 mL of sample volume) filled with a density gradient,
supporting the pH gradient, for preventing electrodecanta-
tion phenomena (i.e. sedimentation of the denser, focused
protein zones that would occur in free liquid) [1–3]. An entire
experiment, including column setup, focusing, elution and
the analysis of hundreds of fractions, required a minimum
of 1 week of hard labor. Notwithstanding the intensive labor
involved, the trend towards large-scale preparative fractiona-
tion devices continued over the years. Thus, in 1975, Rilbe
and Pettersson described two additional types of columns,
this time extremely short and thick, one with a column vol-
ume of 440 mL, the other accommodating 110 mL of sample
volume. In such columns, more than 1 g of sperm whale
myoglobin could be fractionated, the main band containing
as much as 800 mg protein, an appreciable amount to be
carried by a density gradient [4]. Abandoning vertical density
gradient columns, Rilbe’s group started developing multi-
compartment electrolyzers (MCEs) still based on the IEF
fractionation principle. The first of such electrolyzers was
built with 20 chambers and could be filled with up to
1000 mL of sample, with a load capacity of several grams of
protein per day (separations were over in a 24-h period) [5]. As
a last evolutionary step, a mammoth-size apparatus was
described [6], containing 46 separation compartments,
accommodating a total volume of 7.6 L and encompassing a
length of 1 m. Fourteen grams of whey proteins could be
completely separated into its main components (i.e. serum
albumin, a-lactalbumin and b-lactoglobulin).
With the advent of IPGs [7], preparative separations were
still implemented on a rather large scale. The first pre-
parative attempts contemplated focusing on progressively
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thicker IPG gels (5 mm thick), first in standard 5%T, 4%C
matrices [8, 9] and then in progressively diluted polyacryl-
amide matrices, down to as low as 2.8%T, cast in horizontal
troughs filled with 125 mL of total gel volume [10]. Upon
realizing the severe drawbacks of preparative runs in gel
matrices, Righetti’s group reverted to the idea of MCE,
exploiting the fine Immobiline chemistry. Such devices
exploited the unique idea of isoelectric, buffering, zwitter-
ionic membranes, able to confine groups of proteins,
according to their pI values, into any compartment delimited
by two membranes of precise pI value [11, 12]. Also these
electrolyzers (six sample collection chambers plus two elec-
trode reservoirs) were meant for processing large sample
volumes and sizeable protein amounts, since they were con-
nected to external reservoirs from which a continuous sam-
ple feed was guaranteed via recycling.
In recent years, however, due to the development of high-
sensitivity protein analysis techniques, including mass spec-
trometers able to handle minute (of the order of picomole)
sample levels, the trend has been towards miniaturization
even in preparative instrumentation. Additionally, due to the
extreme complexity of any proteome [13], prefractionation by
any means (chromatographic and electrophoretic) has now
become a common trend [14]. Aware of this new trend, the
MCE with isoelectric membranes was miniaturized, so as to
adapt it to proteome prefractionation with minute sample
amounts [15]. The new instrument was shown to perform
quite well in collecting proteome subfractions of very precise
pI intervals, void of contamination from adjacent pI species
[16–18]. An interesting variant of this approach is off-gel IEF
in multicompartment devices [19–21]. If a series of chambers
(up to 20), containing the proteome sample to be sub-
fractionated, are placed directly on top of an IPG gel, in any
desired pH interval, which is subjected to a voltage gradient,
the sample proteins will move along the IPG migration path
till reaching their pI value and thus collecting, at null surface
charge, into the cup standing directly over the IPG gel seg-
ment titrating such species to their respective pI value. Just
like the original MCE with isoelectric membranes, off-gel
IEF permits collection of proteins in solution, a most desir-
able feature when proteins have to be further analyzed for
ascertaining their identity. This instrument too was shown to
perform quite well for fractionation not only of proteins, but
also of their tryptic digests [22–24].
Notwithstanding the advantages of proteome pre-
fractionation in IPG-based separation processes (high preci-
sion in pH gradient engineering, very high resolution,
retrieval of sample uncontaminated by carrier ampholytes
(CAs)), separations in conventional IEF in soluble ampho-
teric buffers have also been adopted recently, especially in the
Rotofor system (and in the mini-Rotofor version) [25]. The
Rotofor is assembled from 20 sample chambers, separated
by liquid-permeable nylon screens, except at the extremities,
where cation- and anion-exchange membranes are placed
against the anodic and cathodic compartments, respectively,
so as to prevent diffusion within the sample chambers of
noxious electrodic products. At the end of the preparative
run, 20 focused fractions are collected simultaneously by
piercing a septum at the chambers’ bottom via 20 needles
connected to a vacuum source. The narrow-pI range frac-
tions can then be used for generating conventional 2-D
maps. In recent times, this methodology has taken another,
unexpected turn: the Rotofor is used directly as the first di-
mension of a peculiar 2-D methodology, in which each frac-
tion is further analyzed by hydrophobic interaction chroma-
tography, using nonporous RP HPLC [26]. Each peak col-
lected from the HPLC column is then digested with trypsin,
subjected to MALDI-TOF MS analysis and MS-Fit database
searching. More recently, Xiao et al. [27] have reported an
unexpected application of the Rotofor, not just for fractiona-
tion of intact proteins in the presence of CAs, but for frac-
tionation of peptide digests of an entire proteome (in this
case, human serum) in an ampholyte-free environment. The
peptides themselves would act as CA-buffers and create a pH
gradient via an “autofocusing” process (with a caveat,
though, the pH gradient will be quite poor, since only a few
peptides have good buffering power and conductivity in the
pH 5–8 range).
Due to the fact that the Rotofor is still a complex machine
to operate and even in its mini-version it handles sizeable
amounts of liquids in each chamber (at least 0.5 mL), we
report here a static apparatus (in that no rotational stabiliza-
tion is adopted), for proteome prefractionation, accom-
modating minute sample volumes (100 mL per chamber)
based on a novel design in the chamber construction and in
the fraction collection at the end of the IEF run.
2 Materials and methods
2.1 Chemicals and biologicals
Urea, SDS, thiourea, CHAPS, Tris, acetic acid, sodium hy-
droxide, Ampholines (pH 3–10), the visible stain Brilliant
Blue G (for colloidal Coomassie blue preparation) and the
Escherichia coli lyophilized cells were all from Sigma-Aldrich
(St Louis, MO). Tributylphosphine (TBP) and acrylamide so-
lution were purchased from Fluka (Buchs, Switzerland). IPG
strips pH 3–10 linear range, Laemmli sample buffer and
Whatman paper were provided by BioRad (Hercules, CA).
Pharmalytes (pH 2.5–5.0 and 5.0–8.0) were purchased from
GE Healthcare (Chalfont St. Giles, UK). The human cancer
cells U2Os were a kind gift from Dr. S. C. Righetti, Istituto
Nazionale dei Tumori, Milan.
2.2 Sample prefractionation by IEF in the static
chamber
The human cancer cells U2Os as well as the E. coli lysates
were directly solubilized in “2-D sample buffer” (7 M
urea, 2 M thiourea, 3% CHAPS, 5 mM TBP and 10 mM
acrylamide) and allowed to be alkylated at room tempera-
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ture for 60 min. To stop the alkylation reaction, 10 mM
DTT was added to the solution, followed by 2.5%
Ampholine pH interval 3–10 (for the U2Os lysate) or 3%
Pharmalyte pH interval 2.5–8.0 (for E. coli proteins,
obtained by mixing 1.5% Pharmalyte 2.5–5.0 and 1.5%
Pharmalyte 5.0–80).
The eight-chambered device was loaded with 960 mL
of cell lysate (120 mL per trough), whereas the anodic and
cathodic chambers were filled with Whatman paper
soaked with 250 mL of 50 mM free acetic acid (pH 3.0) at
the anode and 50 mM free sodium hydroxide (pH 12.0) at
the cathode, respectively. The two electrolytes were dis-
solved in the same solution as the one used for protein
solubilization. The total amount of sample loaded was
1 mg. Focusing was continued for up to 3 h by setting a
limiting power of 1 W, which allowed for a ramp voltage
going from 300 to 1000 V at room temperature. At the
end of the run, the eight fractions were collected and an-
alyzed by SDS-PAGE and by 2-D mapping.
2.3 SDS-PAGE
Mono-dimensional SDS-PAGE of the samples collected
from the present fractionation instrument was performed
using 10-well, 1 mm thick, 13% polyacrylamide glycine
gel plates. Fifteen microliters of each fraction was mixed
with Laemmli sample buffer 26 and boiled for 5 min,
after that 30 mL of the eight mixtures were loaded per lane
and electrophoretic migration performed at 130 V until
bromophenol blue, added as a running marker, reached
the gel bottom. Staining and destaining were performed
with colloidal Coomassie blue and a 7% acetic acid water
solution, respectively.
2.4 2-D PAGE analysis
Seven-centimeter long IPG strips (BioRad) pH 3–10 were
rehydrated with 150 mL of protein solution (60 mL of the
content of each chamber as per Section 2.2, diluted to
150 mL with 2-D sample buffer), for 4 h. IEF was carried
out with an initial voltage gradient from 100 up to 1000 V,
followed by 1000 V constant for 5 h. The voltage was then
increased again rapidly up to 5000 V in 30 min, and kept
at such a value until reaching 30 kVh. For the second di-
mension, the IPG strips were laid on a 10–20% acryl-
amide gradient SDS-PAGE. The electrophoretic run was
performed by setting a current of 5 mA/gel for 1 h, fol-
lowed by 10 mA/gel for 1 h and 20 mA/gel until the dye
front reached the bottom of the gel. Gels were then
immediately stained in colloidal Coomassie blue.
Destaining was performed in 7% acetic acid until the
background became completely transparent. The 2-DE
gels were scanned with a VersaDoc Imaging System
(Model 3000, BioRad).
3 Results
3.1 Description of the instrument
Figure 1 gives drawings of the cell block (A and B) and a
photograph (top view, C) of the assembled instrument.
Basically, the instrument consists of three main acetal-
polyoxymethylene (POM) blocks assembled onto an
869 cm2 base. In the fixed block (part A), eight sample
wells are machined, having the following size: 7 mm
width, 3 mm depth and 10 mm height, each accom-
modating 100–120 mL of sample volume. At the two
extremities, anodic and cathodic compartments are carved
into the block, having the same width and height as the
sample chambers, but with a depth of 6 mm, thus
accepting up to 250 mL of electrodic solutions. The wells
are visible in Fig. 1B, in which the mobile block (part B)
has been removed. The novel idea in this construction is
how the content of the various chambers is isolated from
the neighbouring ones at the end of the IEF run. This is
obtained by acting on the mobile block (part B), that acts
onto a rubber wall (Viton seal). During IEF operation, the
rubber wall is withdrawn by approximately 1 mm, so that
the liquid overflows from the diaphragms separating the
various chambers, thus ensuring liquid continuity and
current flow. At the end of the IEF run, by turning the
black knob, the mobile block B is pressed against the
rubber wall, automatically sealing all the chambers. The
content of each chamber is then withdrawn with a syringe
or directly with an eight-tip pipette.
Figure 1. Drawings of the miniaturized free IEF instrument for
proteome prefractionation (A and B) and photograph of the
actual apparatus in operation (C). Automatic fractionation is
achieved, at the end of focusing, by pressing the movable
block B against the rubber wall (Viton seal). Panel B shows the
profile of the ten chambers in the absence of the movable
block B.
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3.2 Performance of the instrument
Figure 2 gives the evolution of current versus time, for two
different applied voltages. It can be seen that, in both cases,
focusing is obtained in ca. 20 min, not surprisingly, con-
sidering that the electrode distance is only 7 cm. Figure 3
gives the formation of pH gradient as a function of focusing
time. It can be appreciated that the pH gradient is already
formed after a 15 min run and is maintained (and fully
developed) after 45 min of focusing. When running the
multichamber device in presence of proteins, focusing is
continued for up to 3 h, so as to ensure reaching a steady-
state for all the proteins present in the sample. When meas-
uring the conductivity profile of the liquid in the eight
chambers, one obtains a U-shaped function, with a mini-
mum at approx. pH 6–7, as well known in IEF (not shown)
[28].
Figure 2. Evolution of current (I) vs. time for two different volt-
ages applied (300 V, continuous tracing and 100 V, dotted line).
Figure 3. Time course of pH gradient formation. The horizontal
line represents the pH prior to focusing. The slanted and broken
line indicates the theoretical pH predicted for 3–10 ampholytes in
an eight-chambered device. The circles and squares represent
the pH measured after 15 and 45 min of focusing, respectively.
3.3 Biological results
In order to assess the performance in proteome pre-
fractionation of this novel instrument, we have selected a
total cell lysate of the human cancer cells U2Os and the
water-soluble protein fraction of E. coli. Figures 4–6 display
the results of these experiments. Panel (A) of Fig. 4 shows a
2-D map of a control, unfractionated total human cancer cell
lysate, run in an IPG pH 3–10 in the first dimension. Panel
(B) shows the mono-dimensional SDS-PAGE profiling of the
contents of each chamber after fractionation on a 3–10 pH
gradient (below the fraction nos., the pH value of each eluted
fraction is reported). It can be appreciated that the SDS pat-
terns are specific for each isoelectric fraction. In order to see
how precise the pI cuts are, 2-D maps of some eluted frac-
tions are displayed in Fig. 5. These maps are related to frac-
tion nos. 1 (pH 4.33, upper right), 3 (pH 5.76, bottom)
Figure 4. Analysis of a total cell lysate of human cancer cells
U2Os. (A) Control 2-D map of the cell lysate in an IPG pH 3–10
interval. (B) Mono-dimensional SDS-PAGE of the content of each
chamber after focusing in the minidevice shown in Fig. 1 using
3% Ampholine pH interval 3–10. Below the fraction no. the pH of
each fraction is reported.
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Figure 5. 2-D maps of the content of chambers 1 (upper left
panel), 3 (bottom panel) and 6 (upper right panel) panels, after
fractionating the total cell lysate in the device of Fig. 1 for 1 h on a
3–10 pH interval (2.5% ampholine). No spot overlap is experi-
enced in the various chambers.
and 6 (pH 8.84, upper right). It can be appreciated that they
display quite narrow pI cuts, with essentially no spot over-
laps among the different fractions. In order to prove that
steady-state conditions had been reached, the experiment
was repeated with an E. coli total cell lysate, that was run for 1
and 3 h on a 2.5–8.0 pH interval. It can be appreciated
(Fig. 6A–C) that the two 2-D profiles obtained from the same
fractions after 1- or 3-h fractionation are quite similar, indi-
cating that even the shorter focusing times are adequate for
ensuring proper separations.
4 Discussion
As stated in Section 1, although prefractionation exploiting
the IPG methodology has been preferred up to the present,
more and more reports have appeared in the last few years
dealing with prefractionation via conventional IEF in soluble
CA buffers. Although we have reported only a few, selected
applications based on the Rotofor, other instruments exist for
performing this task, such as continuous flow (CF) IEF de-
vices, as epitomized by the Octopus [29], allowing the collec-
tion of as many as 96 fractions. For instance, Hoffman et al.
[30] have proposed CF-IEF as the first dimension of a 2-D
map, the eluted fractions being directly analyzed by ortho-
gonal SDS-PAGE. In turn, individual bands in the second
SDS dimension were eluted and analyzed by ESI-IT-MS. By
this approach, they could identify a number of cytosolic pro-
teins of a human colon carcinoma cell line. One advantage of
CF-IEF (and of course of all the focusing techniques in a gel-
free environment) is immediately evident from their data:
large proteins (e.g. vinculin, Mr 116.6 kDa) could be well
recovered and easily identified; on the contrary, recovery of
large Mr species has always been problematic in IPG gels. In
addition to that, it is also known that IPG matrices tend to
adsorb irreversibly hydrophobic and membrane proteins,
rendering thus problematic their recovery and identification.
All these phenomena do not occur when IEF is performed in
a plain liquid phase, which probably accounts for the popu-
larity of the Rotofor instrument. Our minidevice greatly
simplifies the approach to gel-free IEF: it is compact, it
allows for very small sample volumes (as little as 100 mL), for
very simple fraction recovery and it disposes of the rotational
stabilization implemented in the Rotofor. In fact, in our sys-
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Figure 6. Time course of a fractionation of a total E. coli lysate in
the present instrument on a 2.5–8.0 pH gradient (3% Pharmalyte
2.5–8.0). (A) 2-D map of a control, unfractionated lysate. (B) 2-D
maps of the content of three chambers (2, 5 and 8) after 1 h of
focusing. (C) 2-D maps of the content of three chambers (2, 5 and
8) after 3 h of focusing.
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tem, we do not experience any electrodecantation of proteins
at (or in proximity of) their pI value, possibly because, since
most proteome fractionation and analysis protocols call for a
strongly denaturing mixture of urea and thiourea, the den-
sity of such solutions would prevent protein sedimentation
in a free-liquid phase.
Another way of performing prefractionation for pro-
teome analysis is the well-known “Radola technique” [31],
already described in the early 1970s, consisting in focusing
on a horizontal trough filled with Sephadex beads. This
method has been recently re-introduced by Görg et al. [32].
However, this last approach again exploits a gel phase, which
means scooping up segments of the Sephadex bed between
anode and cathode and eluting the isoelectric fractions for
further analysis.
Perhaps one of the major drawbacks of IEF in CA buffers
is that the fractionation of alkaline proteins is not quite so
good. This is not due to the short focusing times of 1 h (see
Figs. 5 and 6B), since experiments run for longer times (see
Fig. 6C) still show poor focusing in the alkaline region. In
fact, while in the acidic region longer prefractionation times
seem to produce slightly better pI cuts, as it can be appre-
ciated in fraction 3 (Fig. 6C), which presents a slightly better
resolution and a considerable protein enrichment with
respect to the same fraction displayed in Fig. 6B, such an
amelioration cannot be observed in the alkaline interval (see
fraction 8, Figs. 6B and C, bottom panels). This could possi-
bly be due to the onset of electroendoosmotic flow, an ever-
present hazard in all IEF experiments in the presence of sol-
uble CA buffers. Our group recently identified the major
problem: essentially all the commercial brands of CAs, in the
alkaline region, contain a majority of “poor” species, i.e. of
CAs displaying rather large (pI–pK) values, thus unable to
focus and properly buffer along the pH gradient [33]. Thus,
an improvement in the synthesis of alkaline CA buffers is
sorely needed.
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